Zolgensma, the first drug in the U.S. to cross the $1 million mark, is an important test for the field as a wave of gene therapies advance.

Researchers from the University of Pennsylvania analyzed data on 23,442 oncologists in the U.S., evaluating how often doctors affiliated with National Cancer Institute-designated centers were covered by lower-cost insurance plans.

The number of Americans whose cancers were diagnosed at the earliest stage, when its most likely to be cured, increased after Obamacare went into effect and more citizens had access to health insurance, a new study found.

Pfizer Inc. and Allergan Plc agreed to combine in a record $160 billion deal, creating a drugmaking behemoth called Pfizer Plc with products from Viagra to Botox and a low-cost tax base.

New guidelines from the American Cancer Society cut back on the need for mammograms, though they apply only to women with average risk of breast cancer.

The biggest entitlement legislation in a generation is causing barely a ripple in corporate America.

CVS Health Corp. posted fourth-quarter earnings that beat analyst estimates as demand for medicine outweighed the drop in revenue from a decision to stop selling tobacco products.

Measles could once again become native in the United States, disease experts worry, as an outbreak in California linked to Disneyland has put a spotlight on a growing failure to vaccinate thats helping the disease to spread.